InsidersTradesSigma
Follow the 三友医疗 stock price and the full directors' dealings record of the company, a listed issuer based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 三友医疗 has recorded 17 reports. Market capitalisation: €4.8bn. The latest transaction was reported on 18 March 2026 (Sale). Among the most active insiders: Michael Mingyan Liu. Every trade is accessible without an account.
17
Insider Decl.
n/a
Thresholds
€2m
6 ops.
Buy Volume
€18m
11 ops.
Sell Volume
14Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 16,133 of 28,835 companies
48.7
score / 100
Value29
Quality69
FCF yld0.8%
Earn yld1.3%
EV/EBITDA50.8x
ROE1.7%
Gross mgn75%
Net mgn12%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 March 2026
Declarations17 total
1,400,000 sharesA股XSHGSSE:173000009288462400
40,377 sharesA股XSHGSSE:173000007349662460
33,000 sharesA股XSHGSSE:173000007349664350
260,778 sharesA股XSHGSSE:173000007346710800
219,922 sharesA股XSHGSSE:173000007346702900
435,936 sharesA股XSHGSSE:173000006753872400
260,023 sharesA股XSHGSSE:173000006749286050
254,041 sharesA股XSHGSSE:173000006745501280
252,120 sharesA股XSHGSSE:173000006739219940
432,310 sharesA股XSHGSSE:173000006736740200
197,344 sharesA股XSHGSSE:173000006736351680
68,226 sharesA股XSHGSSE:173000006729948670
17 of 17 declarations
About 三友医疗
三友医疗 is a company specializing in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on the development and manufacturing of innovative medical products.